for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-EMA Approves Comirnaty COVID-19 Vaccine For Children Aged 5 To 11

Nov 25 (Reuters) - European Medicines Agency:

* EMA ON PFIZER COVID-19 VACCINE: COMIRNATY COVID-19 VACCINE: EMA RECOMMENDS APPROVAL FOR CHILDREN AGED 5 TO 11

* EMA SAYS THE VACCINE, DEVELOPED BY BIONTECH AND PFIZER, IS ALREADY APPROVED FOR USE IN ADULTS AND CHILDREN AGED 12 AND ABOVE.

* EMA SAYS IN CHILDREN FROM 5 TO 11 YEARS OF AGE, DOSE OF COMIRNATY WILL BE LOWER THAN THAT USED IN PEOPLE AGED 12 AND ABOVE (10 ΜG COMPARED WITH 30 ΜG).

* EMA: AS IN THE OLDER AGE GROUP, IT IS GIVEN AS TWO INJECTIONS IN THE MUSCLES OF THE UPPER ARM, THREE WEEKS APART.

* EMA: CONCLUDED BENEFITS OF COMIRNATY IN CHILDREN AGED 5 TO 11 OUTWEIGH RISKS, PARTICULARLY IN THOSE WITH CONDITIONS THAT INCREASE RISK OF SEVERE COVID-19

* EMA SAYS THE CHMP WILL NOW SEND ITS RECOMMENDATION TO THE EUROPEAN COMMISSION, WHICH WILL ISSUE A FINAL DECISION. Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up